MDM2 had a relatively low but stable expression among multiple organ systems according to the results from the GTEx dataset in our study, and it was significantly highly expressed in the tumor tissues of ccRCC patients (TCGA dataset). The gene discussed is MDM2; the disease is nonpapillary renal cell carcinoma.